Business Context and Reporting Period
This Form 8-K is a current report filed by Klotho Neurosciences, Inc. (not Greenland Mines Ltd) on June 10, 2025. The registrant is a Delaware corporation with its principal executive offices in Omaha, NE. The filing addresses a material definitive agreement regarding warrant repricing and a correction to a prior report on unregistered equity sales.
Key Financial Metrics and Transactions
- Warrant Repricing: The exercise price of Public Warrants (Symbol: KLTOW) was temporarily reduced from $3.49 to $1.35.
- Repricing Window: The reduced price is effective from 9:30 AM on June 10, 2025, until 4:00 PM on June 20, 2025. If not exercised within this window, the price reverts to $3.49.
- Equity Sale Correction: The Company corrected a prior report regarding a June 5, 2025, Stock Purchase Agreement. The total purchase price was $500,000 for 6,250,000 shares of common stock (previously misstated).
- Liquidity and Debt: The filing text does not provide clear values for revenue, profit, cash flow, margins, or total debt.
Material Changes and Corrections
- Warrant Terms: A one-time, limited-time repricing was executed to facilitate warrant exercises, representing a significant change in the terms of the April 2022 Public Warrants.
- Share Count Correction: The number of shares sold in the June 5 private placement was corrected to 6,250,000 shares. The transaction was conducted under Section 4(2) of the Securities Act of 1933 without underwriters or commissions.
Outlook, Risks, and Management Commentary
- Management Action: The Company is actively managing its capital structure through warrant repricing and private placements.
- Investor Action Required: Holders of Public Warrants wishing to exercise at the reduced price must contact their stock brokers before the June 20, 2025, deadline.
- Risks: The filing does not explicitly detail new risks, though the temporary nature of the warrant repricing implies a risk of dilution if warrants are exercised, or a reversion to higher strike prices if the window closes.
Key Facts for Investor Verification
- Verify the exact number of outstanding Public Warrants to assess potential dilution from the $1.35 exercise price.
- Confirm the identity of the purchaser in the $500,000 private placement and any associated lock-up agreements.
- Monitor the Company's cash position post-transaction to determine if the $500,000 infusion is sufficient for near-term operational needs.
- Check the Nasdaq listing status for both Common Stock (KLTO) and Warrants (KLTOW) for any trading halts or delisting notices related to these events.